Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing

Por Caudle, K E, Thorn, C F, Klein, T E, Swen, J J, McLeod, H L, Diasio, R B, Schwab, M
Publicado em 2013

Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism

Por Sanchez Spitman, A. B., Moes, D. J. A. R., Gelderblom, H., Dezentje, V. O., Swen, J.J., Guchelaar, H. J.
Publicado no Eur J Clin Pharmacol (2017)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

Por Swen, J. J., van der Straaten, T., Wessels, J. A. M., Bouvy, M. L., Vlassak, E. E. W., Assendelft, W. J. J., Guchelaar, H.-J.
Publicado em 2011

A comparison of the guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group

Por Bank, P.C.D., Caudle, K.E., Swen, J.J., Gammal, R.S., Whirl-Carrillo, M., Klein, T.E., Relling, M.V., Guchelaar, H.-J.
Publicado no Clin Pharmacol Ther (2017)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Por Hicks, J K, Swen, J J, Thorn, C F, Sangkuhl, K, Kharasch, E D, Ellingrod, V L, Skaar, T C, Müller, D J, Gaedigk, A, Stingl, J C
Publicado em 2013

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients

Por Moes, D. J. A. R, van der Bent, S. A. S, Swen, J. J., van der Straaten, T., Inderson, A., Olofsen, E., Verspaget, H. W., Guchelaar, H. J., den Hartigh, J., van Hoek, B.
Publicado no Eur J Clin Pharmacol (2015)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation

Por Moes, D J A R, Swen, J J, den Hartigh, J, van der Straaten, T, van der Heide, J J Homan, Sanders, J S, Bemelman, F J, de Fijter, J W, Guchelaar, H J
Publicado em 2014